Share This Article:
Identifiable biomarkers may provide objective evidence in proving a Long COVID claim. A recent report highlights developments in identifying the risk of Long COVID through immune profiling.
SARS-CoV-2 infection can result in the development of a constellation of persistent sequelae following acute disease called post-acute sequelae of COVID-19 (PASC) or Long COVID1–3.
Individuals diagnosed with Long COVID frequently report unremitting fatigue, post-exertional malaise, and a variety of cognitive and autonomic dysfunctions1–3; however, the basic biological mechanisms responsible for these debilitating symptoms are unclear.
By Jon L. Gelman
Courtesy of Workers' Compensation
Read Also
About The Author
About The Author
- WorkersCompensation.com
More by This Author
- May 11, 2023
- WorkersCompensation.com
- May 10, 2023
- WorkersCompensation.com
- Mar 30, 2023
- WorkersCompensation.com
Read More
- Oct 19, 2023
- Bill Zachry
- Oct 12, 2023
- Liz Carey
- Sep 28, 2023
- F.J. Thomas
- Sep 28, 2023
- WorkersCompensation.com
- Sep 15, 2023
- Chris Parker